Nanotechnology for multimodal synergistic cancer therapy

W Fan, B Yung, P Huang, X Chen - Chemical reviews, 2017 - ACS Publications
The complexity, diversity, and heterogeneity of tumors seriously undermine the therapeutic
potential of treatment. Therefore, the current trend in clinical research has gradually shifted …

Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy

M Ashrafizadeh, K Hushmandi… - Bioengineering & …, 2023 - Wiley Online Library
Green chemistry has been a growing multidisciplinary field in recent years showing great
promise in biomedical applications, especially for cancer therapy. Chitosan (CS) is an …

Drug delivery systems for programmed and on-demand release

P Davoodi, LY Lee, Q Xu, V Sunil, Y Sun, S Soh… - Advanced drug delivery …, 2018 - Elsevier
With the advancement in medical science and understanding the importance of
biodistribution and pharmacokinetics of therapeutic agents, modern drug delivery research …

Recent advances in nanoparticle-based cancer drug and gene delivery

N Amreddy, A Babu, R Muralidharan… - Advances in cancer …, 2018 - Elsevier
Effective and safe delivery of anticancer agents is among the major challenges in cancer
therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability …

[書籍][B] Handbook of encapsulation and controlled release

M Mishra - 2015 - books.google.com
Written at a level comprehensible to non-experts, this handbook covers the current state of
encapsulation and controlled released technologies, presenting the fundamental processes …

Co-delivery of drugs and plasmid DNA for cancer therapy

PY Teo, W Cheng, JL Hedrick, YY Yang - Advanced drug delivery reviews, 2016 - Elsevier
Cancer is an extremely complex disease involving multiple signaling pathways that enable
tumor cells to evade programmed cell death, thus making cancer treatment extremely …

Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy

SS Qi, JH Sun, HH Yu, SQ Yu - Drug delivery, 2017 - Taylor & Francis
To achieve superior therapeutic efficacy, the combination chemotherapy using two or more
anticancer drugs in clinical practice has been generally accepted as a feasible strategy. On …

Precise control of PLG microsphere size provides enhanced control of drug release rate

C Berkland, M King, A Cox, KK Kim, DW Pack - Journal of controlled release, 2002 - Elsevier
An important limitation in the development of biodegradable polymer microspheres for
controlled-release drug delivery applications has been the difficulty of specifically designing …

Recent advances in delivery of drug–nucleic acid combinations for cancer treatment

J Li, Y Wang, Y Zhu, D Oupický - Journal of controlled release, 2013 - Elsevier
Cancer treatment that uses a combination of approaches with the ability to affect multiple
disease pathways has been proven highly effective in the treatment of many cancers …

Combination antitumor therapy with targeted dual-nanomedicines

W Dai, X Wang, G Song, T Liu, B He, H Zhang… - Advanced drug delivery …, 2017 - Elsevier
Combination therapy is one of the important treatment strategies for cancer at present.
However, the outcome of current combination therapy based on the co-administration of …